(MedPage Today) — Care at the end of life for heart failure patients has grown progressively more expensive — but with a shift toward greater use of hospice care, two studies from the U.S. and Canada have found.
No Comments »
Filed under: General Health News
(MedPage Today) — The first clinical trial of a human embryonic stem cell (ESC) therapy has enrolled its first patient, according to the company sponsoring the study.
No Comments »
Filed under: General Health News
(MedPage Today) — The directors of the CDC and the National Institutes of Health have condemned the U.S. government-funded study in the 1940s that deliberately infected dozens of Guatemalans with sexually transmitted diseases, calling it “regrettable and deeply saddening.”
No Comments »
Filed under: General Health News
(MedPage Today) — An inhaled version of the antipsychotic drug loxapine for treating agitation in patients with schizophrenia or bipolar disorder won’t be approved anytime soon.
No Comments »
Filed under: Pharmacy News
(MedPage Today) — A delayed-release formulation of the osteoporosis drug risedronate, which may be easier for some patients to take, has won FDA approval, its manufacturer announced.
No Comments »
Filed under: Pharmacy News
Columbia Laboratories, Inc. announced today that the U.S. Patent and Trademark Office (USPTO) has issued Watson Pharmaceuticals, Inc. a Notice of Allowance for a key patent for the use of progesterone to treat or prevent preterm birth. The USPTO issues a Notice of Allowance to report that a patent application has been examined and is [...]
No Comments »
Filed under: Pharmacy News
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that data from its Phase 3 (FAME) clinical trials for Iluvien will be presented this month at the annual meeting of the American Academy of Ophthalmology (AAO) in Chicago.
No Comments »
Filed under: Pharmacy News
A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
No Comments »
Filed under: Pharmacy News
Albireo today announced positive top-line results from a Phase IIb study in chronic idiopathic constipation (CIC) assessing efficacy and safety of three different dose levels (5, 10 and 15 mg orally once a day) of the investigational drug A3309 during an eight week trial. Analyses of the data show clinically meaningful and statistically significant improvement [...]
No Comments »
Filed under: Pharmacy News
Helix BioPharma Corp. today announced that it has completed its definitive GLP, rodent and primate, repeat-dose toxicology studies with L-DOS47. These studies demonstrated a good safety profile in an expanded number of rodent and primate test animals, building upon Helix’s positive findings from its preliminary non-GLP toxicology studies.
No Comments »
Filed under: Pharmacy News
